NEOGAP Therapeutics AB
Luigi Notari is a highly experienced Senior Research Scientist specializing in Biochemistry and Molecular Biology, currently working at NEOGAP Therapeutics AB since November 2018. Prior to this role, Luigi Notari served as a Senior Postdoctoral Fellow and Förskare at Stockholm University from November 2013 to January 2018. Previous positions include Animal Biologist at NIH through Kelly Services (2012-2013), Research Associate at the University of Maryland School of Medicine (2008-2012), and Research Instructor at Georgetown University (2007-2008). Luigi Notari's early career included a Postdoctoral Visiting Fellowship at the National Institutes of Health (2002-2007) and a Graduate Student position at Università degli Studi di Pavia (1998-2002). Luigi Notari obtained a Ph.D. in Biochemistry from Università di Pavia and a Bachelor of Science and Master of Science in Biochemistry and Molecular Biology from Università degli Studi di Genova.
This person is not in any offices
NEOGAP Therapeutics AB
NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.